Active

DEVANTHINIC PHARMA

Switched

BE0506893294

Rechtspersoon Private limited company 1 establishment

Rue des Canadiens 24, 7180 Seneffe Activiteiten van holdings

Active for

11 year, 8 months

Financials

Financial year 2025

Gross margin

€ 1.3 million

▼ 6% vs 2024

Profit

Healthy

€ 888,590

▼ 10% vs 2024

Debts

Low

€ 8.7 million

▼ 10% vs 2024

DEVANTHINIC PHARMA from Seneffe, company number BE0506893294, closed financial year 2025 with a result of € 888,590 after tax. For that financial year DEVANTHINIC PHARMA recorded a gross margin of € 1.3 million and equity of € 7.7 million. Compared with financial year 2024, the result moved from € 983,178 to € 888,590. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.

What happened at DEVANTHINIC PHARMA?

What happened at DEVANTHINIC PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 888,590 (▼ 10% vs 2024). filed late Source: NBB ↗
  • New establishment in Seneffe. KBO
  • Anne André became a director. NBB
  • Start of the company according to the CBE. KBO

In short

From € 825,089 profit in 2021 to € 888,590 profit in 2025.

Paid € 891,558 in corporate taxes since 2021.

Best year ever: 2022, with € 1.8 million profit.

On average € 157,100 of value added per employee in 2025.

A new publication or filing at DEVANTHINIC PHARMA? We notify you, reason included.

Follow DEVANTHINIC PHARMA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Behind DEVANTHINIC PHARMA is Anne André. It owns 100% of PHARMACIE DE SENEFFE CENTRE, 100% of PHARMACIE DE LA GRAND RUE, 100% of PHARMACIE BASCOUP, 100% of PHARMACIE LOISEAU, 100% of PHARMACIE DE BESONRIEUX CENTRE and 100% of PHARMA-LOUVE itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Anne André

Director

Also active at: PHARMACIE DE BASCOUP, Pharmacie LOISEAU, PHARMACIE DE LA GRAND RUE +2 more

since 2014

Establishments

Establishment units

Physical locations of this company

Registered office

Rue des Canadiens 24

7180 Seneffe

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0506.893.294
VAT number
BE 0506.893.294
Registered office
Rue des Canadiens 24, 7180 Seneffe
Names & denominations
DEVANTHINIC PHARMA
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
16 December 2014
Peppol
Active · Active since 29 Dec 2025
Activities · NACE

Activiteiten van holdings

Overige zakelijke dienstverlening, neg

Holdings

Frequently asked questions

What is the enterprise number of DEVANTHINIC PHARMA?
The enterprise number of DEVANTHINIC PHARMA is BE0506893294.
What is the address of DEVANTHINIC PHARMA?
The registered office of DEVANTHINIC PHARMA is located at Rue des Canadiens 24, 7180 Seneffe.
When was DEVANTHINIC PHARMA founded?
DEVANTHINIC PHARMA was founded on 16 December 2014.
What is the main activity of DEVANTHINIC PHARMA?
The main activity of DEVANTHINIC PHARMA is "Activiteiten van holdings" (NACE code 64210).
Does DEVANTHINIC PHARMA have a website?
No website is currently known for DEVANTHINIC PHARMA.
How much profit did DEVANTHINIC PHARMA make in 2025?
DEVANTHINIC PHARMA posted a profit after taxes of € 888,590 in financial year 2025.
What is the revenue of DEVANTHINIC PHARMA?
As a small company, DEVANTHINIC PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,319,368.
How many employees does DEVANTHINIC PHARMA have?
According to the 2025 annual accounts, DEVANTHINIC PHARMA has 8.4 full-time equivalents (FTE).
Where can I find the annual accounts of DEVANTHINIC PHARMA?
DEVANTHINIC PHARMA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of DEVANTHINIC PHARMA?
According to the 2025 annual accounts, the directors of DEVANTHINIC PHARMA are: Anne André.
Who owns DEVANTHINIC PHARMA?
Behind DEVANTHINIC PHARMA is Anne André. It owns 100% of PHARMACIE DE SENEFFE CENTRE, 100% of PHARMACIE DE LA GRAND RUE, 100% of PHARMACIE BASCOUP, 100% of PHARMACIE LOISEAU, 100% of PHARMACIE DE BESONRIEUX CENTRE and 100% of PHARMA-LOUVE itself.